T320

· Nanolattix Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T320, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors [Phase 1]

See pricing